Coronavirus 2-DG drug: Regulator nod cuts little ice with doctors; experts flag unreliable clinical data
However, as per the details uploaded on the trial registry only 40 patients participated in the phase 2 trials. Even as the central government has launched the 2-DG (2-deoxy-D-Glucose) drug which it has claimed reduces the recovery time and oxygen requirement of Coronavirus patients, a large section of experts and medical fraternity have expressed doubts … Read more
